2025-05-02 09:07:03
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Torrent Pharmaceuticals Ltd reports Q4FY21 consolidated PAT of Rs. 324 crores
Posted On : 2021-05-18 19:08:35( TIMEZONE : IST )
TORRENT PHARMACEUTICALS LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.1976 crores during the period ended March 31, 2021 as compared to Rs.2003 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.324 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.297 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.19.16 for the period ended March 31, 2021 as compared to Rs.17.52 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 1976 crs | ₹ 2003 crs |  -1.35% |
| Net Profit | ₹ 324 crs | ₹ 297 crs |  9.09% |
| EPS | ₹ 19.16 | ₹ 17.52 | 9.36% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.1976 crores during the period ended March 31, 2021 as compared to Rs.1961 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.324 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.314 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.19.16 for the period ended March 31, 2021 as compared to Rs.18.56 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 1976 crs | ₹ 1961 crs | 0.76% |
| Net Profit | ₹ 324 crs | ₹ 314 crs | 3.18% |
| EPS | ₹ 19.16 | ₹ 18.56 | 3.23% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.8062 crores during the 12 months period ended March 31, 2021 as compared to Rs.8061 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.1252 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.1025 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.73.98 for the 12 months period ended March 31, 2021 as compared to Rs.60.55 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 8062 crs | ₹ 8061 crs | 0.01% |
| Net Profit | ₹ 1252 crs | ₹ 1025 crs | 22.15% |
| EPS | ₹ 73.98 | ₹60.55 | 22.18% |
Shares of TORRENT PHARMACEUTICALS LTD. was last trading in BSE at Rs.2731.45 as compared to the previous close of Rs. 2764.75. The total number of shares traded during the day was 11175 in over 1231 trades.
The stock hit an intraday high of Rs. 2800 and intraday low of 2715.7. The net turnover during the day was Rs. 30671556.
